Sphera Funds Management Ltd. Essa Pharma Inc. Transaction History

Sphera Funds Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.18 - $14.44 $2.61 Million - $6.1 Million	-422,461 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.8 - $14.38 $366,139 - $675,011	-46,941 Reduced 10.0%	422,461 $6 Million
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $1.39 Million - $5.25 Million	-178,901 Reduced 27.6%	469,402 $3.76 Million
Q2 2021 Aug 17, 2021	BUY	$24.17 - $34.28 $4.33 Million - $6.14 Million	179,062 Added 38.16%	648,303 $18.5 Million
Q1 2021 May 17, 2021	BUY	$11.61 - $32.08 $917,666 - $2.54 Million	79,041 Added 20.26%	469,241 $13.6 Million
Q4 2020 Feb 16, 2021	BUY	$5.47 - $12.1 $766,894 - $1.7 Million	140,200 Added 56.08%	390,200 $4.66 Million
Q3 2020 Nov 12, 2020	BUY	$6.0 - $7.79 $1.5 Million - $1.95 Million	250,000 New	250,000 $1.73 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $75.4M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.